基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the detailed record of transactions filed by Chione Ltd. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Cumulatively, 4 reports have been recorded. Split: 1 buy · 3 sells. Total volume traded: €4.9m. History available since 17 November 2022. The latest transaction was filed on 26 June 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Chione Ltd is a declarant linked to Acrivon Therapeutics, Inc. on XNAS. In the 4 filings on record, the sampled transactions run from 2022-11-21 to 2023-06-28, with EUR 4810000 of buys and EUR 45923 of sells.